News

CORE Explores Presbyopia Pharmacological Treatments in New Publication

The Centre for Ocular Research & Education (CORE) has focused Issue 75 of Contact Lens Update to exploring current and future pharmacological treatments, and how they compare to multifocal contact lenses.

Read More

Myopia Profile’s My Kids Vision Makes Strides in Community Impact

Internationally Recognized Platform Witnessed Exponential Growth and Positive Patient Outcomes in 2023

Read More

Long-Time OGS Donor Shares Perspectives Following Visit to Vietnam

Robert Weiss visited the Optometry School and Pediatric Eye Care Center.

Read More

KALEOS, for Today’s Man

Designed in Barcelona, and handmade, this frame, with a revisited retro look featuring a captivating gradient acetate, and enhanced with metal rivets.

Read More

MiSight® 1 day Six-Year Study Findings Verified, Companion Video Offers Highlights for ECPs

Seminal Study Details Published in Ophthalmic and Physiological Optics, Affirming CooperVision Myopia Control Leadership

Read More

OGS Earns Four-Star Rating from Charity Navigator

Optometry Giving Sight (OGS) announces that its strong financial health and ongoing accountability and transparency have earned a Four-Star Rating from Charity Navigator.

Read More

FYihealth group Announces Trevor Bartlett as New Chief Operating Officer

Joining as Chief Operating Officer, Bartlett’s extensive background includes experience in large, fast-growing companies such as Sobeys, Rexall, and Giant Tiger. Bartlett will be overseeing FYihealth group’s Operations, Retail Optical, Product, Supply Chain, and Marketing.

Read More

opti 2024 Boosts Desire for Lenses

In addition to market players from the contact lens sector at opti 2024, highly customised iris shootings will ensure more focus on the lens.

Read More

Inface Eyewear: Wombat, Casual but Edgy

Inface’s Wombat (model number 9531) is the small, compact newcomer in our titanium rim concept.

Read More

Trinity Capital Provides $45 Million Growth Capital To Neurolens

Trinity Capital Inc., a leading provider of diversified financial solutions to growth-stage companies, announced the commitment of $45 million in growth capital to Neurolens.

Read More
1 18 19 20 21 22 391